Australia markets close in 5 hours 16 minutes

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
107.94-1.58 (-1.44%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 14.74B
Enterprise value 14.37B
Trailing P/E 133.26
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)39.37
Price/book (mrq)12.21
Enterprise value/revenue 37.61
Enterprise value/EBITDA 129.17

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 32.17%
S&P500 52-week change 326.44%
52-week high 3144.00
52-week low 397.51
50-day moving average 3115.28
200-day moving average 3123.72

Share statistics

Avg vol (3-month) 3275.27k
Avg vol (10-day) 3226.81k
Shares outstanding 5136.58M
Implied shares outstanding 6136.58M
Float 843.77M
% held by insiders 174.17%
% held by institutions 110.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 40.46%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.73%
5-year average dividend yield 4N/A
Payout ratio 461.73%
Dividend date 3N/A
Ex-dividend date 425 May 2023
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 29.23%
Operating margin (ttm)-2.85%

Management effectiveness

Return on assets (ttm)5.47%
Return on equity (ttm)9.28%

Income statement

Revenue (ttm)382.23M
Revenue per share (ttm)2.78
Quarterly revenue growth (yoy)17.50%
Gross profit (ttm)N/A
EBITDA 104.77M
Net income avi to common (ttm)111.73M
Diluted EPS (ttm)0.81
Quarterly earnings growth (yoy)-28.90%

Balance sheet

Total cash (mrq)388.05M
Total cash per share (mrq)2.84
Total debt (mrq)11.3M
Total debt/equity (mrq)0.94%
Current ratio (mrq)10.47
Book value per share (mrq)8.84

Cash flow statement

Operating cash flow (ttm)111.65M
Levered free cash flow (ttm)-163.15M